Links between mTOR and the immunoproteasome: Therapeutic targets for cardiac hypertrophy?

被引：2
|
作者：
Ackermann, Maegen A. [1 ]
机构：
[1] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Wexner Coll Med, Columbus, OH 43210 USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2015年 / 89卷
关键词：
UBIQUITIN-PROTEASOME SYSTEM; NF-KAPPA-B; MAMMALIAN TARGET; CARDIOMYOCYTE SURVIVAL; MYOCARDIAL-ISCHEMIA; PROTEIN-SYNTHESIS; DOWN-REGULATION; LIFE-SPAN; RAPAMYCIN; INHIBITION;
D O I：
10.1016/j.yjmcc.2015.09.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 115
页数：3
相关论文
共 50 条
  • [41] Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy
    Wang, Xuejun
    Cui, Taixing
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 313 (02): : H304 - H319
  • [42] Differences between pathological and physiological cardiac hypertrophy: Novel therapeutic strategies to treat heart failure
    McMullen, Julie R.
    Jennings, Garry L.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (04): : 255 - 262
  • [43] Therapeutic potentials of modulating autophagy in pathological cardiac hypertrophy
    Shi, Shenggan
    Jiang, Peidu
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [44] Molecular basis of therapeutic effects of β-hydroxybutyrate on cardiac hypertrophy
    Jin, S.
    Shen, G.
    Tang, Y. C.
    Gu, P. Y.
    Xu, J.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (05): : 1547 - 1557
  • [45] Relationship between cardiac hypertrophy and microalbuminuria
    Ruilope, LM
    HYPERTENSION AND THE HEART, 1997, 432 : 135 - 143
  • [46] Therapeutic Targets and Personalized Medicine in Cardiac Disease
    Vafiadaki, Elizabeth
    Turnbull, Irene C.
    Sanoudou, Despina
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (11):
  • [47] Possible therapeutic targets in cardiac myocyte apoptosis
    Andreka, P
    Nadhazi, Z
    Muzes, G
    Szantho, G
    Vandor, L
    Konya, L
    Turner, MS
    Tulassay, Z
    Bishopric, NH
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (20) : 2445 - 2461
  • [48] Long noncoding RNAs in the mTOR signaling network: biomarkers and therapeutic targets
    Huang, Tinglei
    Wang, Meiling
    Huang, Bo
    Chang, Augustus
    Liu, Feng
    Zhang, Yanjie
    Jiang, Bin
    APOPTOSIS, 2018, 23 (5-6) : 255 - 264
  • [49] mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets
    Shi, Jingxuan
    Liu, Xinze
    Jiao, Yuanyuan
    Tian, Jingwei
    An, Jiaqi
    Zou, Guming
    Zhuo, Li
    GENES & DISEASES, 2025, 12 (02)
  • [50] Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas
    Liu, Mei
    Lin, Yong
    Zhang, Xian-Chao
    Tan, Yu-Huan
    Yao, Yue-Liang
    Tan, Juan
    Zhang, Xia
    Cui, You-Hong
    Liu, Xindong
    Wang, Yan
    Bian, Xiu-Wu
    LABORATORY INVESTIGATION, 2017, 97 (11) : 1354 - 1363
12345